User profiles for Emmanuel Clave

Emmanuel Clave

Université de Paris, INSERM UMRS1160
Verified email at univ-paris-diderot.fr
Cited by 5606

[HTML][HTML] Evaluating thymic function after human hematopoietic stem cell transplantation in the personalized medicine era

A Gaballa, E Clave, M Uhlin, A Toubert… - Frontiers in …, 2020 - frontiersin.org
Hematopoietic stem cell transplantation (HSCT) is an effective treatment option for several
malignant and non-malignant hematological diseases. The clinical outcome of this procedure …

[HTML][HTML] Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation

…, WM Linehan, NS Young, E Clave… - … England Journal of …, 2000 - Mass Medical Soc
Background Since allogeneic stem-cell transplantation can induce curative graft-versus-leukemia
reactions in patients with hematologic cancers, we sought to induce analogous graft-…

The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment

E Velardi, E Clave, LCM Arruda, F Benini… - Seminars in …, 2021 - Springer
As the thymus represents the primary site of T-cell development, optimal thymic function is
of paramount importance for the successful reconstitution of the adaptive immunity after …

A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation

K Talvensaari, E Clave, C Douay… - Blood, The Journal …, 2002 - ashpublications.org
Cord blood (CB) is used increasingly as a source of hematopoietic stem cells because of a
lower risk of acute and chronic graft-versus-host disease (GVHD). However, there is some …

Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units

JJ Molldrem, E Clave, YZ Jiang… - Blood, The Journal …, 1997 - ashpublications.org
We previously showed that a peptide (PR1) derived from the primary granule enzyme
proteinase 3 induced peptide specific cytotoxic T lymphocytes (CTL) in a normal HLA-A2.1 + …

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation

E Clave, M Busson, C Douay… - Blood, The Journal …, 2009 - ashpublications.org
Long-term T-cell reconstitution after hematopoietic stem cell transplantation (HSCT) is
dependent on patient thymic function and affected by graft-versus-host disease (GVHD). To …

Th17/Treg ratio in human graft-versus-host disease

…, K Keyvanfar, M Robin, E Clave… - Blood, The Journal …, 2010 - ashpublications.org
Th17 cells have never been explored in human graft-versus-host disease (GVHD). We studied
the correlation between the presence of Th17 cells with histologic and clinical parameters…

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis

…, D Ilie, C Douay, N Mounier, E Clave… - Arthritis & …, 2005 - Wiley Online Library
Objective To analyze hematopoietic and immune reconstitution after autologous hematopoietic
stem cell transplantation (HSCT) in 7 patients with systemic sclerosis (SSc). Methods …

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

…, D Mavroudis, J Tisdale, J Molldrem, E Clave… - Bone marrow …, 1998 - nature.com
Thirty-eight patients with hematological malignancies, received T cell-depleted marrow
transplants (BMT) and cyclosporine to prevent acute graft-versus-host disease (aGVHD), …

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus …

RW Childs, E Clave, J Tisdale, M Plante… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: A 50-year-old man developed progressive pulmonary metastasis resistant to
interferon alfa-2b treatment 7 months after he underwent left nephrectomy for stage III renal cell …